Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I6XA
|
|||
| Former ID |
DNC004384
|
|||
| Drug Name |
(2R,3S)-3-(6-Amino-purin-9-yl)-nonan-2-ol
|
|||
| Synonyms |
3-(6-Amino-purin-9-yl)-nonan-2-ol
Click to Show/Hide
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H23N5O
|
|||
| Canonical SMILES |
CCCCCCC(C(C)O)N1C=NC2=C(N=CN=C21)N
|
|||
| InChI |
1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17)/t10-,11+/m1/s1
|
|||
| InChIKey |
IOSAAWHGJUZBOG-MNOVXSKESA-N
|
|||
| CAS Number |
CAS 79813-68-6
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:63058
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The next generation of phosphodiesterase inhibitors: structural clues to ligand and substrate selectivity of phosphodiesterases. J Med Chem. 2005 May 19;48(10):3449-62. | |||
| REF 2 | Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors. J Med Chem. 1995 May 12;38(10):1720-35. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.